- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產品
- 聯(lián)系我們
別名: RG7321
Pictilisib (GDC-0941, RG7321) 是一種有效的PI3Kα/δ抑制劑,在無細胞試驗中IC50為 3 nM,對p110β (11倍)和p110γ (25倍)具有適度的選擇性。Pictilisib (GDC-0941) 可誘導自噬和凋亡。Phase 2。
Pictilisib (GDC-0941) Chemical Structure
CAS: 957054-30-7
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
SKOV3 | Growth Inhibition Assay | 1 μM | 96 h | GI50=0.1476 μM | 23360348 |
MCF7 | Growth Inhibition Assay | 1 μM | 96 h | GI50=0.0702 μM | 23360348 |
SKOV3 | Kinase Assay | 1 μM | 1 h | Inhibition of PI3Kalpha assessed as inhibition of Akt Ser473 phosphorylation | 23360348 |
U87MG | Cytotoxic Assay | 72 h | IC50=7.77 μM | 23059545 | |
A549 | Cytotoxic Assay | 72 h | IC50=6.9 μM | 23059545 | |
NCI-H226 | Cytotoxic Assay | 72 h | IC50=2.9 μM | 23059545 | |
SGC7901 | Cytotoxic Assay | 72 h | IC50=1.8 μM | 23059545 | |
HepG2 | Cytotoxic Assay | 72 h | IC50=1 μM | 23059545 | |
HT-29 | Cytotoxic Assay | 72 h | IC50=0.66 μM | 23059545 | |
H460 | Cytotoxic Assay | 72 h | IC50=0.87 μM | 23059545 | |
NCI-H1975 | Cytotoxic Assay | 72 h | IC50=0.27 μM | 23059545 | |
MCF7.1 | Growth Inhibition Assay | 72 h | EC50=0.72 μM | 20346656 | |
MCF7.1 | Growth Inhibition Assay | 72 h | Antiproliferative activity against human MCF7.1 cells expressing PI3Kalpha mutant with IC50 of 0.34 μM | 20050669 | |
PC3 | Growth Inhibition Assay | 72 h | Antiproliferative activity against human PC3 cells deficient in PTEN with IC50 of 0.39 μM | 20050669 | |
MCF7.1 | Growth Inhibition Assay | 72 h | Antiproliferative activity against human MCF7.1 cells expressing PI3Kalpha mutant with EC50 of 0.39 μM | 21985639 | |
PC3 | Growth Inhibition Assay | 72 h | EC50=0.34 μM | 21985639 | |
MCF7-neo/Her2 | Growth Inhibition Assay | 72 h | IC50=0.29 μM | 23662903 | |
MCF7.1 | Growth Inhibition Assay | 72 h | Antiproliferative activity against human MCF7.1 cells expressing HER2 gene with IC50 of 0.28 μM | 21981714 | |
PC3 | Growth Inhibition Assay | 72 h | IC50=0.28 μM | 21981714 | |
Sf9 | Kinase Assay | 1 h | Inhibition of GST-fused human recombinant PI3Kalpha expressed | 23540645 | |
Sf9 | Kinase Assay | 1 h | Inhibition of GST-fused human recombinant PI3Kgamma expressed | 23540645 | |
Sf9 | Kinase Assay | 1 h | Inhibition of GST-fused human recombinant PI3Kdelta expressed | 23540645 | |
Sf9 | Kinase Assay | 1 h | Inhibition of GST-fused human recombinant PI3Kbeta expressed in baculovirus infected SF9 cells with IC50 of 0.017 μM | 23540645 | |
RAW 264.7 | Kinase Assay | 90 min | Inhibition of human PI3Kgamma expressed assessed as inhibition of AKT phosphorylation with IC50 of 0.298 μM | 22548342 | |
Sf9 | Kinase Assay | 30 min | Inhibition of human PI3Kgamma expressed assessed as amount of ATP consumed with IC50 of 0.042 μM | 22548342 | |
U87MG | Growth Inhibition Assay | 96 h | IC50=0.95 μM | 18754654 | |
PC3 | Growth Inhibition Assay | 96 h | IC50=0.28 μM | 18754654 | |
A2780 | Growth Inhibition Assay | 96 h | Antiproliferative activity against human A2780 cells with PIK3CA and PTEN mutation with IC50 of 0.14 μM | 18754654 | |
MDA-MB-361 | Growth Inhibition Assay | 96 h | Antiproliferative activity against human MDA-MB-361 cells with PIK3CA E545-K mutation with IC50 of 0.72 μM | 18754654 | |
U87MG | Function Assay | 2 h | Inhibition of Akt Ser473 phosphorylation in PTEN-null human U87MG cells with IC50 of 0.046 μM | 18754654 | |
PC3 | Function Assay | 2 h | Inhibition of Akt Ser473 phosphorylation in PTEN-null human PC3 cells with IC50 of 0.037 μM | 18754654 | |
MDA-MB-361 | Function Assay | 2 h | Inhibition of Akt Ser473 phosphorylation in human MDA-MB-361 cells with PIK3CA E545-K mutation with IC50 of 0.028 μM | 18754654 | |
Sf9 | Kinase Assay | 1 h | Inhibition of human recombinant PI3K p110alpha expressed in Sf9 cells coexpressing p85alpha | 18754654 | |
Sf9 | Kinase Assay | 1 h | Inhibition of human recombinant PI3K p110beta expressed in Sf9 cells coexpressing p85alpha with IC50 of 0.033 μM | 18754654 | |
Sf9 | Kinase Assay | 1 h | Inhibition of human recombinant PI3K p110beta E545-K mutant expressed in Sf9 cells coexpressing p85alpha with IC50 of 0.003 μM | 18754654 | |
Sf9 | Kinase Assay | 1 h | Inhibition of human recombinant PI3K p110beta H1047-R mutant expressed in Sf9 cells coexpressing p85alpha with IC50 of 0.003 μM | 18754654 | |
Sf9 | Kinase Assay | 1 h | Inhibition of human recombinant PI3K p110delta expressed in Sf9 cells coexpressing p85alpha with IC50 of 0.003 μM | 18754654 | |
HCC2157 | Growth Inhibition Assay | IC50=2.32927 μM | SANGER | ||
D-502MG | Growth Inhibition Assay | IC50=2.32461 μM | SANGER | ||
SF295 | Growth Inhibition Assay | IC50=2.31524 μM | SANGER | ||
SF126 | Growth Inhibition Assay | IC50=2.30625 μM | SANGER | ||
A431 | Growth Inhibition Assay | IC50=2.27354 μM | SANGER | ||
EW-22 | Growth Inhibition Assay | IC50=2.25067 μM | SANGER | ||
NCI-H2030 | Growth Inhibition Assay | IC50=2.24123 μM | SANGER | ||
ES1 | Growth Inhibition Assay | IC50=2.21326 μM | SANGER | ||
HCC1419 | Growth Inhibition Assay | IC50=2.21115 μM | SANGER | ||
CHP-212 | Growth Inhibition Assay | IC50=2.18442 μM | SANGER | ||
NCI-N87 | Growth Inhibition Assay | IC50=2.13384 μM | SANGER | ||
KS-1 | Growth Inhibition Assay | IC50=2.11001 μM | SANGER | ||
NCI-H1048 | Growth Inhibition Assay | IC50=2.1052 μM | SANGER | ||
NH-12 | Growth Inhibition Assay | IC50=2.05424 μM | SANGER | ||
LOXIMVI | Growth Inhibition Assay | IC50=2.04084 μM | SANGER | ||
CAL-39 | Growth Inhibition Assay | IC50=2.0328 μM | SANGER | ||
LAMA-84 | Growth Inhibition Assay | IC50=2.02689 μM | SANGER | ||
SNB75 | Growth Inhibition Assay | IC50=2.01541 μM | SANGER | ||
SK-MES-1 | Growth Inhibition Assay | IC50=2.01332 μM | SANGER | ||
T98G | Growth Inhibition Assay | IC50=1.99006 μM | SANGER | ||
HOS | Growth Inhibition Assay | IC50=1.97948 μM | SANGER | ||
TYK-nu | Growth Inhibition Assay | IC50=1.95823 μM | SANGER | ||
PFSK-1 | Growth Inhibition Assay | IC50=1.94458 μM | SANGER | ||
ME-180 | Growth Inhibition Assay | IC50=1.93477 μM | SANGER | ||
NCI-H526 | Growth Inhibition Assay | IC50=1.9139 μM | SANGER | ||
G-402 | Growth Inhibition Assay | IC50=1.89797 μM | SANGER | ||
BB49-HNC | Growth Inhibition Assay | IC50=1.88692 μM | SANGER | ||
NCI-H2228 | Growth Inhibition Assay | IC50=1.85203 μM | SANGER | ||
EW-16 | Growth Inhibition Assay | IC50=1.85182 μM | SANGER | ||
EGI-1 | Growth Inhibition Assay | IC50=1.84701 μM | SANGER | ||
BT-20 | Growth Inhibition Assay | IC50=1.68902 μM | SANGER | ||
TK10 | Growth Inhibition Assay | IC50=1.67083 μM | SANGER | ||
JVM-3 | Growth Inhibition Assay | IC50=1.64875 μM | SANGER | ||
D-566MG | Growth Inhibition Assay | IC50=1.6253 μM | SANGER | ||
G-401 | Growth Inhibition Assay | IC50=1.62164 μM | SANGER | ||
EFM-19 | Growth Inhibition Assay | IC50=1.6181 μM | SANGER | ||
VA-ES-BJ | Growth Inhibition Assay | IC50=1.6127 μM | SANGER | ||
HuP-T4 | Growth Inhibition Assay | IC50=1.60778 μM | SANGER | ||
Ramos-2G6-4C10 | Growth Inhibition Assay | IC50=1.60746 μM | SANGER | ||
SK-MEL-28 | Growth Inhibition Assay | IC50=1.56085 μM | SANGER | ||
PANC-03-27 | Growth Inhibition Assay | IC50=1.51408 μM | SANGER | ||
A704 | Growth Inhibition Assay | IC50=1.50785 μM | SANGER | ||
639-V | Growth Inhibition Assay | IC50=1.50245 μM | SANGER | ||
MDA-MB-415 | Growth Inhibition Assay | IC50=1.48692 μM | SANGER | ||
BFTC-909 | Growth Inhibition Assay | IC50=1.43305 μM | SANGER | ||
A549 | Growth Inhibition Assay | IC50=1.3997 μM | SANGER | ||
Saos-2 | Growth Inhibition Assay | IC50=1.33205 μM | SANGER | ||
AU565 | Growth Inhibition Assay | IC50=1.31863 μM | SANGER | ||
SK-MEL-1 | Growth Inhibition Assay | IC50=1.30679 μM | SANGER | ||
A498 | Growth Inhibition Assay | IC50=1.30474 μM | SANGER | ||
A4-Fuk | Growth Inhibition Assay | IC50=1.29993 μM | SANGER | ||
KYSE-270 | Growth Inhibition Assay | IC50=1.29734 μM | SANGER | ||
LB996-RCC | Growth Inhibition Assay | IC50=1.22177 μM | SANGER | ||
HuH-7 | Growth Inhibition Assay | IC50=1.20949 μM | SANGER | ||
Hs-578-T | Growth Inhibition Assay | IC50=1.19565 μM | SANGER | ||
CTB-1 | Growth Inhibition Assay | IC50=1.14293 μM | SANGER | ||
HT | Growth Inhibition Assay | IC50=1.13478 μM | SANGER | ||
BFTC-905 | Growth Inhibition Assay | IC50=1.13449 μM | SANGER | ||
D-423MG | Growth Inhibition Assay | IC50=1.09962 μM | SANGER | ||
NCI-H520 | Growth Inhibition Assay | IC50=1.08967 μM | SANGER | ||
TGBC24TKB | Growth Inhibition Assay | IC50=1.08045 μM | SANGER | ||
CAL-54 | Growth Inhibition Assay | IC50=1.07081 μM | SANGER | ||
WM-115 | Growth Inhibition Assay | IC50=1.06656 μM | SANGER | ||
SW1710 | Growth Inhibition Assay | IC50=1.04233 μM | SANGER | ||
EKVX | Growth Inhibition Assay | IC50=1.0129 μM | SANGER | ||
NCI-H1648 | Growth Inhibition Assay | IC50=998.51 nM | SANGER | ||
A101D | Growth Inhibition Assay | IC50=990.19 nM | SANGER | ||
NCI-H292 | Growth Inhibition Assay | IC50=974.32 nM | SANGER | ||
NB5 | Growth Inhibition Assay | IC50=956.6 nM | SANGER | ||
HDLM-2 | Growth Inhibition Assay | IC50=949.2 nM | SANGER | ||
OVCAR-5 | Growth Inhibition Assay | IC50=940.17 nM | SANGER | ||
NCI-H1563 | Growth Inhibition Assay | IC50=915.99 nM | SANGER | ||
SCC-25 | Growth Inhibition Assay | IC50=914.19 nM | SANGER | ||
MCF7 | Growth Inhibition Assay | IC50=898.59 nM | SANGER | ||
OAW-42 | Growth Inhibition Assay | IC50=872.19 nM | SANGER | ||
QIMR-WIL | Growth Inhibition Assay | IC50=865.2 nM | SANGER | ||
H4 | Growth Inhibition Assay | IC50=850.85 nM | SANGER | ||
HSC-3 | Growth Inhibition Assay | IC50=839.54 nM | SANGER | ||
697 | Growth Inhibition Assay | IC50=831.55 nM | SANGER | ||
ES8 | Growth Inhibition Assay | IC50=810.52 nM | SANGER | ||
L-363 | Growth Inhibition Assay | IC50=798.42 nM | SANGER | ||
LNCaP-Clone-FGC | Growth Inhibition Assay | IC50=796.34 nM | SANGER | ||
LoVo | Growth Inhibition Assay | IC50=777.9 nM | SANGER | ||
OMC-1 | Growth Inhibition Assay | IC50=751.09 nM | SANGER | ||
P30-OHK | Growth Inhibition Assay | IC50=730.71 nM | SANGER | ||
SW872 | Growth Inhibition Assay | IC50=727.89 nM | SANGER | ||
SK-NEP-1 | Growth Inhibition Assay | IC50=725.94 nM | SANGER | ||
MV-4-11 | Growth Inhibition Assay | IC50=724.31 nM | SANGER | ||
D-263MG | Growth Inhibition Assay | IC50=718.1 nM | SANGER | ||
EPCL-272H | Growth Inhibition Assay | IC50=687.21 nM | SANGER | ||
HO-1-N-1 | Growth Inhibition Assay | IC50=659.17 nM | SANGER | ||
NEC8 | Growth Inhibition Assay | IC50=653.57 nM | SANGER | ||
HuO-3N1 | Growth Inhibition Assay | IC50=642.38 nM | SANGER | ||
ES4 | Growth Inhibition Assay | IC50=639.54 nM | SANGER | ||
IGROV-1 | Growth Inhibition Assay | IC50=634.31 nM | SANGER | ||
MOLT-4 | Growth Inhibition Assay | IC50=623.62 nM | SANGER | ||
T47D | Growth Inhibition Assay | IC50=597.56 nM | SANGER | ||
NKM-1 | Growth Inhibition Assay | IC50=593.09 nM | SANGER | ||
BHT-101 | Growth Inhibition Assay | IC50=544.94 nM | SANGER | ||
MG-63 | Growth Inhibition Assay | IC50=541.11 nM | SANGER | ||
PA-1 | Growth Inhibition Assay | IC50=532.41 nM | SANGER | ||
COLO-684 | Growth Inhibition Assay | IC50=523.11 nM | SANGER | ||
LB1047-RCC | Growth Inhibition Assay | IC50=522.93 nM | SANGER | ||
A204 | Growth Inhibition Assay | IC50=522.33 nM | SANGER | ||
KU-19-19 | Growth Inhibition Assay | IC50=516.07 nM | SANGER | ||
NBsusSR | Growth Inhibition Assay | IC50=488.85 nM | SANGER | ||
LXF-289 | Growth Inhibition Assay | IC50=448.27 nM | SANGER | ||
MDA-MB-361 | Growth Inhibition Assay | IC50=439.13 nM | SANGER | ||
GCIY | Growth Inhibition Assay | IC50=433.8 nM | SANGER | ||
HL-60 | Growth Inhibition Assay | IC50=425.75 nM | SANGER | ||
MFE-280 | Growth Inhibition Assay | IC50=418.2 nM | SANGER | ||
NB7 | Growth Inhibition Assay | IC50=389.83 nM | SANGER | ||
CHL-1 | Growth Inhibition Assay | IC50=378.65 nM | SANGER | ||
GAMG | Growth Inhibition Assay | IC50=370.85 nM | SANGER | ||
MDA-MB-175-VII | Growth Inhibition Assay | IC50=352.92 nM | SANGER | ||
ES7 | Growth Inhibition Assay | IC50=341.99 nM | SANGER | ||
AN3-CA | Growth Inhibition Assay | IC50=340.37 nM | SANGER | ||
BPH-1 | Growth Inhibition Assay | IC50=314 nM | SANGER | ||
YH-13 | Growth Inhibition Assay | IC50=304.32 nM | SANGER | ||
NCI-H1623 | Growth Inhibition Assay | IC50=304.08 nM | SANGER | ||
LB2241-RCC | Growth Inhibition Assay | IC50=303.84 nM | SANGER | ||
DOK | Growth Inhibition Assay | IC50=301.7 nM | SANGER | ||
RS4-11 | Growth Inhibition Assay | IC50=261.76 nM | SANGER | ||
NB69 | Growth Inhibition Assay | IC50=245.27 nM | SANGER | ||
HGC-27 | Growth Inhibition Assay | IC50=212.57 nM | SANGER | ||
NOS-1 | Growth Inhibition Assay | IC50=211.82 nM | SANGER | ||
HAL-01 | Growth Inhibition Assay | IC50=206.73 nM | SANGER | ||
HuO9 | Growth Inhibition Assay | IC50=206.02 nM | SANGER | ||
NCI-H1770 | Growth Inhibition Assay | IC50=123.86 nM | SANGER | ||
MHH-PREB-1 | Growth Inhibition Assay | IC50=114.3 nM | SANGER | ||
HH | Growth Inhibition Assay | IC50=111.08 nM | SANGER | ||
ES5 | Growth Inhibition Assay | IC50=50.21 nM | SANGER | ||
PC3 | Growth Inhibition Assay | logGI50=-6.66 M | 22336246 | ||
DU145 | Growth Inhibition Assay | logGI50=-5.85 M | 22336246 | ||
MKN74 | Growth Inhibition Assay | logGI50=-6.02 M | 22336246 | ||
MKN45 | Growth Inhibition Assay | logGI50=-6.55 M | 22336246 | ||
MKN28 | Growth Inhibition Assay | logGI50=-5.52 M | 22336246 | ||
MKN7 | Growth Inhibition Assay | logGI50=-6.50 M | 22336246 | ||
MKN1 | Growth Inhibition Assay | logGI50=-7.08 M | 22336246 | ||
St-4 | Growth Inhibition Assay | logGI50=-5.56 M | 22336246 | ||
ACHN | Growth Inhibition Assay | logGI50=-6.07 M | 22336246 | ||
RXF631L | Growth Inhibition Assay | logGI50=-6.88 M | 22336246 | ||
SKOV3 | Growth Inhibition Assay | logGI50=-6.52 M | 22336246 | ||
OVCAR8 | Growth Inhibition Assay | logGI50=-5.73 M | 22336246 | ||
OVCAR5 | Growth Inhibition Assay | logGI50=-6.26 M | 22336246 | ||
OVCAR4 | Growth Inhibition Assay | logGI50=-5.76 M | 22336246 | ||
OVCAR3 | Growth Inhibition Assay | logGI50=-6.71 M | 22336246 | ||
LOXIMVI | Growth Inhibition Assay | logGI50=-6.29 M | 22336246 | ||
DMS114 | Growth Inhibition Assay | logGI50=-5.92 M | 22336246 | ||
DMS273 | Growth Inhibition Assay | logGI50=-6.43 M | 22336246 | ||
A549 | Growth Inhibition Assay | logGI50=-6.15 M | 22336246 | ||
NCI-H483 | Growth Inhibition Assay | logGI50=-6.56 M | 22336246 | ||
NCI-H522 | Growth Inhibition Assay | logGI50=-6.58 M | 22336246 | ||
NCI-H226 | Growth Inhibition Assay | logGI50=-6.21 M | 22336246 | ||
NCI-H23 | Growth Inhibition Assay | logGI50=-5.73 M | 22336246 | ||
HCT116 | Growth Inhibition Assay | logGI50=-5.87 M | 22336246 | ||
HCT15 | Growth Inhibition Assay | logGI50=-6.12 M | 22336246 | ||
HT-29 | Growth Inhibition Assay | logGI50=-6.30 M | 22336246 | ||
KM12 | Growth Inhibition Assay | logGI50=-5.76 M | 22336246 | ||
HCC2998 | Growth Inhibition Assay | logGI50=-6.29 M | 22336246 | ||
SNB78 | Growth Inhibition Assay | logGI50=-6.52 M | 22336246 | ||
SNB75 | Growth Inhibition Assay | logGI50=-7.10 M | 22336246 | ||
SF539 | Growth Inhibition Assay | logGI50=-6.50 M | 22336246 | ||
SF295 | Growth Inhibition Assay | logGI50=-6.37 M | 22336246 | ||
SF268 | Growth Inhibition Assay | logGI50=-5.39 M | 22336246 | ||
U251 | Growth Inhibition Assay | logGI50=-5.50 M | 22336246 | ||
MDA-MB-231 | Growth Inhibition Assay | logGI50=-5.46 M | 22336246 | ||
MCF7 | Growth Inhibition Assay | logGI50=-7.33 M | 22336246 | ||
HBC5 | Growth Inhibition Assay | logGI50=-6.60 M | 22336246 | ||
BSY1 | Growth Inhibition Assay | logGI50=-6.90 M | 22336246 | ||
HBC4 | Growth Inhibition Assay | logGI50=-6.03 M | 22336246 | ||
MCF7-neo/Her2 | Kinase Assay | Inhibition of PI3Kalpha assessed as reduction of AKT phosphorylation at S473 with IC50 of 0.007 μM | 23662903 | ||
D-283MED | Growth Inhibition Assay | IC50=2.35926 μM | SANGER | ||
SNU-423 | Growth Inhibition Assay | IC50=2.40171 μM | SANGER | ||
SK-LU-1 | Growth Inhibition Assay | IC50=2.44586 μM | SANGER | ||
22RV1 | Growth Inhibition Assay | IC50=2.45617 μM | SANGER | ||
SW1088 | Growth Inhibition Assay | IC50=2.49213 μM | SANGER | ||
HT-3 | Growth Inhibition Assay | IC50=2.49259 μM | SANGER | ||
NCI-H1666 | Growth Inhibition Assay | IC50=2.51104 μM | SANGER | ||
EM-2 | Growth Inhibition Assay | IC50=2.51169 μM | SANGER | ||
SNU-449 | Growth Inhibition Assay | IC50=2.57014 μM | SANGER | ||
786-0 | Growth Inhibition Assay | IC50=2.59238 μM | SANGER | ||
SKG-IIIa | Growth Inhibition Assay | IC50=2.65939 μM | SANGER | ||
MEL-HO | Growth Inhibition Assay | IC50=2.67634 μM | SANGER | ||
LCLC-97TM1 | Growth Inhibition Assay | IC50=2.69267 μM | SANGER | ||
MKN7 | Growth Inhibition Assay | IC50=2.70754 μM | SANGER | ||
5637 | Growth Inhibition Assay | IC50=2.71035 μM | SANGER | ||
HOP-92 | Growth Inhibition Assay | IC50=2.74717 μM | SANGER | ||
MDA-MB-157 | Growth Inhibition Assay | IC50=2.82023 μM | SANGER | ||
NB12 | Growth Inhibition Assay | IC50=2.84914 μM | SANGER | ||
DMS-273 | Growth Inhibition Assay | IC50=2.8647 μM | SANGER | ||
HCC70 | Growth Inhibition Assay | IC50=2.86589 μM | SANGER | ||
YKG-1 | Growth Inhibition Assay | IC50=3.03787 μM | SANGER | ||
NCI-H28 | Growth Inhibition Assay | IC50=3.05291 μM | SANGER | ||
HN | Growth Inhibition Assay | IC50=3.06636 μM | SANGER | ||
HT-1080 | Growth Inhibition Assay | IC50=3.08606 μM | SANGER | ||
HPAF-II | Growth Inhibition Assay | IC50=3.10068 μM | SANGER | ||
U-2-OS | Growth Inhibition Assay | IC50=3.13782 μM | SANGER | ||
SNU-387 | Growth Inhibition Assay | IC50=3.16364 μM | SANGER | ||
Becker | Growth Inhibition Assay | IC50=3.16808 μM | SANGER | ||
BHY | Growth Inhibition Assay | IC50=3.25571 μM | SANGER | ||
HTC-C3 | Growth Inhibition Assay | IC50=3.29352 μM | SANGER | ||
M14 | Growth Inhibition Assay | IC50=3.30663 μM | SANGER | ||
COR-L23 | Growth Inhibition Assay | IC50=3.37279 μM | SANGER | ||
C32 | Growth Inhibition Assay | IC50=3.41508 μM | SANGER | ||
Mewo | Growth Inhibition Assay | IC50=3.42182 μM | SANGER | ||
TE-8 | Growth Inhibition Assay | IC50=3.48259 μM | SANGER | ||
RPMI-2650 | Growth Inhibition Assay | IC50=3.60637 μM | SANGER | ||
AGS | Growth Inhibition Assay | IC50=3.62464 μM | SANGER | ||
MZ2-MEL | Growth Inhibition Assay | IC50=3.66138 μM | SANGER | ||
Calu-3 | Growth Inhibition Assay | IC50=3.71287 μM | SANGER | ||
SJSA-1 | Growth Inhibition Assay | IC50=3.71315 μM | SANGER | ||
SW962 | Growth Inhibition Assay | IC50=3.72636 μM | SANGER | ||
PC-14 | Growth Inhibition Assay | IC50=3.73222 μM | SANGER | ||
SW1573 | Growth Inhibition Assay | IC50=3.75348 μM | SANGER | ||
769-P | Growth Inhibition Assay | IC50=3.82743 μM | SANGER | ||
KNS-62 | Growth Inhibition Assay | IC50=3.92338 μM | SANGER | ||
NCI-H747 | Growth Inhibition Assay | IC50=4.05638 μM | SANGER | ||
LN-405 | Growth Inhibition Assay | IC50=4.15728 μM | SANGER | ||
OVCAR-8 | Growth Inhibition Assay | IC50=4.22543 μM | SANGER | ||
DMS-114 | Growth Inhibition Assay | IC50=4.23891 μM | SANGER | ||
NCI-H2126 | Growth Inhibition Assay | IC50=4.24558 μM | SANGER | ||
TCCSUP | Growth Inhibition Assay | IC50=4.24788 μM | SANGER | ||
SK-N-FI | Growth Inhibition Assay | IC50=4.25332 μM | SANGER | ||
HCE-4 | Growth Inhibition Assay | IC50=4.27197 μM | SANGER | ||
DK-MG | Growth Inhibition Assay | IC50=4.3039 μM | SANGER | ||
RO82-W-1 | Growth Inhibition Assay | IC50=4.32584 μM | SANGER | ||
A2780 | Growth Inhibition Assay | IC50=4.36682 μM | SANGER | ||
ETK-1 | Growth Inhibition Assay | IC50=4.37052 μM | SANGER | ||
FADU | Growth Inhibition Assay | IC50=4.37467 μM | SANGER | ||
CAL-12T | Growth Inhibition Assay | IC50=4.41413 μM | SANGER | ||
647-V | Growth Inhibition Assay | IC50=4.44022 μM | SANGER | ||
TGBC1TKB | Growth Inhibition Assay | IC50=4.45113 μM | SANGER | ||
LU-99A | Growth Inhibition Assay | IC50=4.4606 μM | SANGER | ||
CAL-33 | Growth Inhibition Assay | IC50=4.52456 μM | SANGER | ||
LU-134-A | Growth Inhibition Assay | IC50=4.52745 μM | SANGER | ||
NCI-H1355 | Growth Inhibition Assay | IC50=4.55146 μM | SANGER | ||
RPMI-7951 | Growth Inhibition Assay | IC50=4.57002 μM | SANGER | ||
TE-1 | Growth Inhibition Assay | IC50=4.66143 μM | SANGER | ||
OE33 | Growth Inhibition Assay | IC50=4.70511 μM | SANGER | ||
CAL-51 | Growth Inhibition Assay | IC50=4.71082 μM | SANGER | ||
SW1783 | Growth Inhibition Assay | IC50=4.75308 μM | SANGER | ||
BT-474 | Growth Inhibition Assay | IC50=4.76384 μM | SANGER | ||
KYSE-520 | Growth Inhibition Assay | IC50=4.87392 μM | SANGER | ||
8-MG-BA | Growth Inhibition Assay | IC50=4.88557 μM | SANGER | ||
IA-LM | Growth Inhibition Assay | IC50=4.99435 μM | SANGER | ||
SW954 | Growth Inhibition Assay | IC50=4.99443 μM | SANGER | ||
RPMI-8226 | Growth Inhibition Assay | IC50=5.05461 μM | SANGER | ||
MKN1 | Growth Inhibition Assay | IC50=5.07927 μM | SANGER | ||
A375 | Growth Inhibition Assay | IC50=5.09256 μM | SANGER | ||
8305C | Growth Inhibition Assay | IC50=5.09887 μM | SANGER | ||
CAL-62 | Growth Inhibition Assay | IC50=5.18259 μM | SANGER | ||
NB10 | Growth Inhibition Assay | IC50=5.22744 μM | SANGER | ||
OC-314 | Growth Inhibition Assay | IC50=5.37444 μM | SANGER | ||
PSN1 | Growth Inhibition Assay | IC50=5.38286 μM | SANGER | ||
GR-ST | Growth Inhibition Assay | IC50=5.38322 μM | SANGER | ||
P12-ICHIKAWA | Growth Inhibition Assay | IC50=5.401 μM | SANGER | ||
NCI-H1092 | Growth Inhibition Assay | IC50=5.41148 μM | SANGER | ||
SCC-4 | Growth Inhibition Assay | IC50=5.41355 μM | SANGER | ||
TE-6 | Growth Inhibition Assay | IC50=5.41816 μM | SANGER | ||
DOHH-2 | Growth Inhibition Assay | IC50=5.42248 μM | SANGER | ||
SW684 | Growth Inhibition Assay | IC50=5.66385 μM | SANGER | ||
CP50-MEL-B | Growth Inhibition Assay | IC50=5.68684 μM | SANGER | ||
UM-UC-3 | Growth Inhibition Assay | IC50=5.72231 μM | SANGER | ||
LC-2-ad | Growth Inhibition Assay | IC50=5.78251 μM | SANGER | ||
PC-3 | Growth Inhibition Assay | IC50=5.91615 μM | SANGER | ||
CAN | Growth Inhibition Assay | IC50=5.9282 μM | SANGER | ||
ESS-1 | Growth Inhibition Assay | IC50=5.97869 μM | SANGER | ||
ATN-1 | Growth Inhibition Assay | IC50=6.05568 μM | SANGER | ||
BxPC-3 | Growth Inhibition Assay | IC50=6.08219 μM | SANGER | ||
KYSE-150 | Growth Inhibition Assay | IC50=6.12476 μM | SANGER | ||
RPMI-8866 | Growth Inhibition Assay | IC50=6.19163 μM | SANGER | ||
SW780 | Growth Inhibition Assay | IC50=6.2042 μM | SANGER | ||
A388 | Growth Inhibition Assay | IC50=6.23115 μM | SANGER | ||
NCI-H1437 | Growth Inhibition Assay | IC50=6.24073 μM | SANGER | ||
NCI-H1755 | Growth Inhibition Assay | IC50=6.36612 μM | SANGER | ||
LS-123 | Growth Inhibition Assay | IC50=6.40521 μM | SANGER | ||
CaR-1 | Growth Inhibition Assay | IC50=6.46373 μM | SANGER | ||
RT-112 | Growth Inhibition Assay | IC50=6.60338 μM | SANGER | ||
CGT | Growth Inhibition Assay | IC50=6.73681 μM | SANGER | ||
SW626 | Growth Inhibition Assay | IC50=6.73946 μM | SANGER | ||
AsPC-1 | Growth Inhibition Assay | IC50=6.74507 μM | SANGER | ||
SBC-5 | Growth Inhibition Assay | IC50=6.97297 μM | SANGER | ||
SF539 | Growth Inhibition Assay | IC50=6.99333 μM | SANGER | ||
TI-73 | Growth Inhibition Assay | IC50=7.06285 μM | SANGER | ||
MHH-ES-1 | Growth Inhibition Assay | IC50=7.07762 μM | SANGER | ||
KYSE-510 | Growth Inhibition Assay | IC50=7.08432 μM | SANGER | ||
EW-1 | Growth Inhibition Assay | IC50=7.36996 μM | SANGER | ||
SK-OV-3 | Growth Inhibition Assay | IC50=7.39432 μM | SANGER | ||
MC-IXC | Growth Inhibition Assay | IC50=7.41972 μM | SANGER | ||
HSC-2 | Growth Inhibition Assay | IC50=7.42705 μM | SANGER | ||
NCI-H2342 | Growth Inhibition Assay | IC50=7.5149 μM | SANGER | ||
NCI-H1792 | Growth Inhibition Assay | IC50=7.51711 μM | SANGER | ||
HT-1376 | Growth Inhibition Assay | IC50=7.87778 μM | SANGER | ||
EW-13 | Growth Inhibition Assay | IC50=7.89977 μM | SANGER | ||
no-11 | Growth Inhibition Assay | IC50=7.90174 μM | SANGER | ||
Daoy | Growth Inhibition Assay | IC50=7.94321 μM | SANGER | ||
COLO-800 | Growth Inhibition Assay | IC50=8.04162 μM | SANGER | ||
GB-1 | Growth Inhibition Assay | IC50=8.06565 μM | SANGER | ||
SJRH30 | Growth Inhibition Assay | IC50=8.15878 μM | SANGER | ||
NCI-H2291 | Growth Inhibition Assay | IC50=8.29187 μM | SANGER | ||
J82 | Growth Inhibition Assay | IC50=8.29491 μM | SANGER | ||
NCI-H596 | Growth Inhibition Assay | IC50=8.31453 μM | SANGER | ||
RERF-LC-MS | Growth Inhibition Assay | IC50=8.34856 μM | SANGER | ||
RH-18 | Growth Inhibition Assay | IC50=8.35046 μM | SANGER | ||
SW48 | Growth Inhibition Assay | IC50=8.59453 μM | SANGER | ||
RD | Growth Inhibition Assay | IC50=8.59391 μM | SANGER | ||
MS-1 | Growth Inhibition Assay | IC50=8.61387 μM | SANGER | ||
ES6 | Growth Inhibition Assay | IC50=8.73119 μM | SANGER | ||
TE-12 | Growth Inhibition Assay | IC50=8.77505 μM | SANGER | ||
DBTRG-05MG | Growth Inhibition Assay | IC50=8.91217 μM | SANGER | ||
KINGS-1 | Growth Inhibition Assay | IC50=8.92938 μM | SANGER | ||
HLE | Growth Inhibition Assay | IC50=8.93785 μM | SANGER | ||
MHH-NB-11 | Growth Inhibition Assay | IC50=9.01839 μM | SANGER | ||
U-87-MG | Growth Inhibition Assay | IC50=9.24321 μM | SANGER | ||
MN-60 | Growth Inhibition Assay | IC50=9.24542 μM | SANGER | ||
SAS | Growth Inhibition Assay | IC50=9.25581 μM | SANGER | ||
NCI-H446 | Growth Inhibition Assay | IC50=9.361 μM | SANGER | ||
C-33-A | Growth Inhibition Assay | IC50=9.43988 μM | SANGER | ||
RXF393 | Growth Inhibition Assay | IC50=9.47002 μM | SANGER | ||
CGTH-W-1 | Growth Inhibition Assay | IC50=9.49384 μM | SANGER | ||
RCM-1 | Growth Inhibition Assay | IC50=9.63801 μM | SANGER | ||
SN12C | Growth Inhibition Assay | IC50=9.65338 μM | SANGER | ||
KLE | Growth Inhibition Assay | IC50=9.70009 μM | SANGER | ||
EFO-21 | Growth Inhibition Assay | IC50=9.77382 μM | SANGER | ||
KYSE-70 | Growth Inhibition Assay | IC50=9.88011 μM | SANGER | ||
D-247MG | Growth Inhibition Assay | IC50=10.0568 μM | SANGER | ||
MPP-89 | Growth Inhibition Assay | IC50=10.0946 μM | SANGER | ||
RVH-421 | Growth Inhibition Assay | IC50=10.1505 μM | SANGER | ||
NCI-H460 | Growth Inhibition Assay | IC50=10.2806 μM | SANGER | ||
NOMO-1 | Growth Inhibition Assay | IC50=10.3532 μM | SANGER | ||
DEL | Growth Inhibition Assay | IC50=10.3794 μM | SANGER | ||
HT55 | Growth Inhibition Assay | IC50=10.6205 μM | SANGER | ||
MC116 | Growth Inhibition Assay | IC50=10.6655 μM | SANGER | ||
BB30-HNC | Growth Inhibition Assay | IC50=10.669 μM | SANGER | ||
DJM-1 | Growth Inhibition Assay | IC50=10.6949 μM | SANGER | ||
ZR-75-30 | Growth Inhibition Assay | IC50=10.9441 μM | SANGER | ||
U-118-MG | Growth Inhibition Assay | IC50=10.9896 μM | SANGER | ||
MSTO-211H | Growth Inhibition Assay | IC50=11.0716 μM | SANGER | ||
SW837 | Growth Inhibition Assay | IC50=11.0949 μM | SANGER | ||
HuCCT1 | Growth Inhibition Assay | IC50=11.1281 μM | SANGER | ||
RCC10RGB | Growth Inhibition Assay | IC50=11.135 μM | SANGER | ||
NMC-G1 | Growth Inhibition Assay | IC50=11.1493 μM | SANGER | ||
NCI-H650 | Growth Inhibition Assay | IC50=11.3794 μM | SANGER | ||
HEC-1 | Growth Inhibition Assay | IC50=11.4328 μM | SANGER | ||
DU-4475 | Growth Inhibition Assay | IC50=11.7393 μM | SANGER | ||
DSH1 | Growth Inhibition Assay | IC50=11.7606 μM | SANGER | ||
HCC1569 | Growth Inhibition Assay | IC50=11.7678 μM | SANGER | ||
HCC1187 | Growth Inhibition Assay | IC50=11.8588 μM | SANGER | ||
EW-11 | Growth Inhibition Assay | IC50=11.9474 μM | SANGER | ||
LB2518-MEL | Growth Inhibition Assay | IC50=12.059 μM | SANGER | ||
KALS-1 | Growth Inhibition Assay | IC50=12.8553 μM | SANGER | ||
8505C | Growth Inhibition Assay | IC50=12.885 μM | SANGER | ||
SK-N-DZ | Growth Inhibition Assay | IC50=13.0453 μM | SANGER | ||
CHP-134 | Growth Inhibition Assay | IC50=13.1158 μM | SANGER | ||
HCE-T | Growth Inhibition Assay | IC50=13.2364 μM | SANGER | ||
LB-831-BLC | Growth Inhibition Assay | IC50=13.6246 μM | SANGER | ||
OVCAR-4 | Growth Inhibition Assay | IC50=13.6524 μM | SANGER | ||
SW756 | Growth Inhibition Assay | IC50=13.7246 μM | SANGER | ||
OCUB-M | Growth Inhibition Assay | IC50=13.8156 μM | SANGER | ||
SW982 | Growth Inhibition Assay | IC50=13.8276 μM | SANGER | ||
DB | Growth Inhibition Assay | IC50=13.8384 μM | SANGER | ||
H-EMC-SS | Growth Inhibition Assay | IC50=13.9139 μM | SANGER | ||
VMRC-RCZ | Growth Inhibition Assay | IC50=14.0015 μM | SANGER | ||
CAKI-1 | Growth Inhibition Assay | IC50=14.0132 μM | SANGER | ||
GI-1 | Growth Inhibition Assay | IC50=14.0658 μM | SANGER | ||
Ca9-22 | Growth Inhibition Assay | IC50=14.6054 μM | SANGER | ||
TE-5 | Growth Inhibition Assay | IC50=14.7208 μM | SANGER | ||
EFO-27 | Growth Inhibition Assay | IC50=14.7622 μM | SANGER | ||
CAL-72 | Growth Inhibition Assay | IC50=14.7783 μM | SANGER | ||
GP5d | Growth Inhibition Assay | IC50=15.0474 μM | SANGER | ||
CAS-1 | Growth Inhibition Assay | IC50=15.066 μM | SANGER | ||
A2058 | Growth Inhibition Assay | IC50=15.5638 μM | SANGER | ||
PANC-08-13 | Growth Inhibition Assay | IC50=15.6859 μM | SANGER | ||
Detroit562 | Growth Inhibition Assay | IC50=15.9139 μM | SANGER | ||
PANC-10-05 | Growth Inhibition Assay | IC50=16.0821 μM | SANGER | ||
KOSC-2 | Growth Inhibition Assay | IC50=16.1125 μM | SANGER | ||
GT3TKB | Growth Inhibition Assay | IC50=16.1981 μM | SANGER | ||
KM-H2 | Growth Inhibition Assay | IC50=16.3646 μM | SANGER | ||
LB771-HNC | Growth Inhibition Assay | IC50=16.4422 μM | SANGER | ||
SF268 | Growth Inhibition Assay | IC50=16.452 μM | SANGER | ||
OE19 | Growth Inhibition Assay | IC50=16.524 μM | SANGER | ||
MLMA | Growth Inhibition Assay | IC50=16.5571 μM | SANGER | ||
MDA-MB-231 | Growth Inhibition Assay | IC50=16.7136 μM | SANGER | ||
TGW | Growth Inhibition Assay | IC50=16.8102 μM | SANGER | ||
MDA-MB-453 | Growth Inhibition Assay | IC50=17.0003 μM | SANGER | ||
SNU-C2B | Growth Inhibition Assay | IC50=17.0237 μM | SANGER | ||
A427 | Growth Inhibition Assay | IC50=17.2334 μM | SANGER | ||
SK-MEL-2 | Growth Inhibition Assay | IC50=17.3213 μM | SANGER | ||
KURAMOCHI | Growth Inhibition Assay | IC50=17.3897 μM | SANGER | ||
IST-MEL1 | Growth Inhibition Assay | IC50=17.9182 μM | SANGER | ||
NCI-H1793 | Growth Inhibition Assay | IC50=18.1581 μM | SANGER | ||
HCC1395 | Growth Inhibition Assay | IC50=18.5611 μM | SANGER | ||
NUGC-3 | Growth Inhibition Assay | IC50=18.6584 μM | SANGER | ||
BB65-RCC | Growth Inhibition Assay | IC50=18.669 μM | SANGER | ||
RMG-I | Growth Inhibition Assay | IC50=18.7382 μM | SANGER | ||
LS-513 | Growth Inhibition Assay | IC50=18.9228 μM | SANGER | ||
MFM-223 | Growth Inhibition Assay | IC50=19.0716 μM | SANGER | ||
NCI-H727 | Growth Inhibition Assay | IC50=19.3295 μM | SANGER | ||
KP-4 | Growth Inhibition Assay | IC50=19.8531 μM | SANGER | ||
NB13 | Growth Inhibition Assay | IC50=19.8839 μM | SANGER | ||
UACC-893 | Growth Inhibition Assay | IC50=19.9757 μM | SANGER | ||
HT-1197 | Growth Inhibition Assay | IC50=20.2958 μM | SANGER | ||
NCI-H2029 | Growth Inhibition Assay | IC50=20.3266 μM | SANGER | ||
GI-ME-N | Growth Inhibition Assay | IC50=20.3373 μM | SANGER | ||
OVCAR-3 | Growth Inhibition Assay | IC50=20.5822 μM | SANGER | ||
HD-MY-Z | Growth Inhibition Assay | IC50=21.3696 μM | SANGER | ||
NTERA-S-cl-D1 | Growth Inhibition Assay | IC50=21.6722 μM | SANGER | ||
SCH | Growth Inhibition Assay | IC50=22.496 μM | SANGER | ||
KARPAS-299 | Growth Inhibition Assay | IC50=23.3887 μM | SANGER | ||
NCI-H1650 | Growth Inhibition Assay | IC50=23.9241 μM | SANGER | ||
ACHN | Growth Inhibition Assay | IC50=24.4656 μM | SANGER | ||
M059J | Growth Inhibition Assay | IC50=24.5634 μM | SANGER | ||
AM-38 | Growth Inhibition Assay | IC50=25.481 μM | SANGER | ||
KG-1 | Growth Inhibition Assay | IC50=25.5494 μM | SANGER | ||
COLO-824 | Growth Inhibition Assay | IC50=25.5599 μM | SANGER | ||
NCI-H1155 | Growth Inhibition Assay | IC50=25.5847 μM | SANGER | ||
NCI-H441 | Growth Inhibition Assay | IC50=25.7465 μM | SANGER | ||
J-RT3-T3-5 | Growth Inhibition Assay | IC50=26.3027 μM | SANGER | ||
JEG-3 | Growth Inhibition Assay | IC50=26.6805 μM | SANGER | ||
RKO | Growth Inhibition Assay | IC50=26.7632 μM | SANGER | ||
CAL-85-1 | Growth Inhibition Assay | IC50=27.2118 μM | SANGER | ||
CAL-120 | Growth Inhibition Assay | IC50=27.6914 μM | SANGER | ||
NCI-H2452 | Growth Inhibition Assay | IC50=27.7716 μM | SANGER | ||
NCI-H1395 | Growth Inhibition Assay | IC50=27.7833 μM | SANGER | ||
KYSE-450 | Growth Inhibition Assay | IC50=27.9862 μM | SANGER | ||
S-117 | Growth Inhibition Assay | IC50=29.3857 μM | SANGER | ||
SW13 | Growth Inhibition Assay | IC50=29.8519 μM | SANGER | ||
ES3 | Growth Inhibition Assay | IC50=30.3733 μM | SANGER | ||
HCT-116 | Growth Inhibition Assay | IC50=30.5554 μM | SANGER | ||
NCI-H1693 | Growth Inhibition Assay | IC50=30.5942 μM | SANGER | ||
VM-CUB-1 | Growth Inhibition Assay | IC50=30.6413 μM | SANGER | ||
NCI-H2170 | Growth Inhibition Assay | IC50=31.5784 μM | SANGER | ||
ALL-PO | Growth Inhibition Assay | IC50=31.8428 μM | SANGER | ||
NCI-H661 | Growth Inhibition Assay | IC50=32.0623 μM | SANGER | ||
NCI-H2347 | Growth Inhibition Assay | IC50=32.4837 μM | SANGER | ||
FTC-133 | Growth Inhibition Assay | IC50=32.706 μM | SANGER | ||
COLO-829 | Growth Inhibition Assay | IC50=33.3467 μM | SANGER | ||
GOTO | Growth Inhibition Assay | IC50=33.5258 μM | SANGER | ||
YAPC | Growth Inhibition Assay | IC50=33.8159 μM | SANGER | ||
LCLC-103H | Growth Inhibition Assay | IC50=34.1624 μM | SANGER | ||
SiHa | Growth Inhibition Assay | IC50=34.3817 μM | SANGER | ||
LK-2 | Growth Inhibition Assay | IC50=34.5708 μM | SANGER | ||
KP-N-YS | Growth Inhibition Assay | IC50=34.7202 μM | SANGER | ||
NCI-SNU-1 | Growth Inhibition Assay | IC50=35.179 μM | SANGER | ||
KNS-81-FD | Growth Inhibition Assay | IC50=35.663 μM | SANGER | ||
SCC-9 | Growth Inhibition Assay | IC50=36.7146 μM | SANGER | ||
SH-4 | Growth Inhibition Assay | IC50=36.73 μM | SANGER | ||
HCC-1954 | Growth Inhibition Assay | IC50=37.2729 μM | SANGER | ||
BALL-1 | Growth Inhibition Assay | IC50=37.5316 μM | SANGER | ||
BE-13 | Growth Inhibition Assay | IC50=37.7018 μM | SANGER | ||
COLO-678 | Growth Inhibition Assay | IC50=37.9437 μM | SANGER | ||
SK-MEL-3 | Growth Inhibition Assay | IC50=38.2397 μM | SANGER | ||
OAW-28 | Growth Inhibition Assay | IC50=38.639 μM | SANGER | ||
CAMA-1 | Growth Inhibition Assay | IC50=38.9691 μM | SANGER | ||
C2BBe1 | Growth Inhibition Assay | IC50=39.818 μM | SANGER | ||
A3-KAW | Growth Inhibition Assay | IC50=40.3661 μM | SANGER | ||
SK-MEL-24 | Growth Inhibition Assay | IC50=40.5931 μM | SANGER | ||
KYSE-140 | Growth Inhibition Assay | IC50=40.7165 μM | SANGER | ||
MOLT-16 | Growth Inhibition Assay | IC50=41.1536 μM | SANGER | ||
CFPAC-1 | Growth Inhibition Assay | IC50=42.5211 μM | SANGER | ||
NB14 | Growth Inhibition Assay | IC50=42.7027 μM | SANGER | ||
COLO-792 | Growth Inhibition Assay | IC50=42.8961 μM | SANGER | ||
RH-1 | Growth Inhibition Assay | IC50=43.4836 μM | SANGER | ||
NCI-H522 | Growth Inhibition Assay | IC50=44.3568 μM | SANGER | ||
Ca-Ski | Growth Inhibition Assay | IC50=44.8114 μM | SANGER | ||
KGN | Growth Inhibition Assay | IC50=48.3063 μM | SANGER | ||
UACC-62 | Growth Inhibition Assay | IC50=48.4072 μM | SANGER | ||
NCI-H358 | Growth Inhibition Assay | IC50=49.3018 μM | SANGER | ||
LS-411N | Growth Inhibition Assay | IC50=49.3118 μM | SANGER | ||
IST-MES1 | Growth Inhibition Assay | IC50=49.5625 μM | SANGER | ||
點擊查看更多細胞系數(shù)據(jù) |
產品描述 | Pictilisib (GDC-0941, RG7321) 是一種有效的PI3Kα/δ抑制劑,在無細胞試驗中IC50為 3 nM,對p110β (11倍)和p110γ (25倍)具有適度的選擇性。Pictilisib (GDC-0941) 可誘導自噬和凋亡。Phase 2。 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | GDC-0941也等效作用于PI3Kα和 PI3Kδ和PI3Kα突變型E545-K和H1047-R,也選擇性作用于PI3Kβ(10倍)和 PI3Kγ(25倍), 選擇性更高地作用于PI3K II, III, 和IV類成員,包括, C2β, Vps34, DNA-PK和mTOR。GDC-0941 作用于U87MG, PC3, 和 MDA-MB-361 細胞,有效抑制Akt磷酸化,IC50分別為46 nM, 37 nM,和 28 nM。GDC-0941抑制U87MG, A2780, PC3, 和MDA-MB-361細胞增殖,IC50分別為 0.95 μM, 0.14 μM, 0.28 μM, 和0.72 μM。[1]GDC-0941抑制含PIK3CA突變的HER2擴增的細胞增殖,IC50<500 nM, 且有效抑制HER2 擴增乳腺癌細胞增殖和活力。[2]GDC-0941 顯著抑制HCT116, DLD1和 HT29細胞生長,GI50分別為1081 nM, 1070 nM 和157 nM。[4] |
|||
---|---|---|---|---|
激酶實驗 | 閃爍接近檢測 | |||
使用p85α調節(jié)亞基,使重組人PI3Kα, PI3Kβ, 和PI3Kδ在 Sf9 桿狀病毒系統(tǒng)中共表達,在谷胱甘肽-瓊脂糖凝膠上進行親和層析而純化GST-融合蛋白。重組人 PI3Kγ表達作為單體 GST融合,也想上述相似方法純化。GDC-0941 溶于DMSO,加到含200 μg硅酸釔(Ysi) 聚賴氨酸SPA 磁珠, 4 mM MgCl2, 1 mM 二硫蘇糖醇 (DTT), 1 μM ATP, 0.125 μCi [γ-33P]-ATP, 和4% (v/v) DMSO的20 mM Tris-HCl (pH 7.5)上,總體積為 50 μL。PI3Kα (5 ng), PI3Kβ(5 ng), PI3Kδ(5 ng), 或PI3Kγ(5 ng)的重組GST-融合 ,加到實驗混合物中,開始激酶反應。在室溫下溫育1小時后, 加入150 μL PBS終止反應?;旌衔镌?000 rpm 轉速下離心2分鐘,然后使用Wallac Microbeta計數(shù)器讀數(shù)。在 MDL Assay Explorer系統(tǒng)中使用S型,劑量-反應曲線,計算進行至少2次獨立重復實驗,取平均值,作為IC50值。 | ||||
細胞實驗 | 細胞系 | SKBR-3, BT474-M1, AU-565, HCC-1419, ZR75-30, KPL-4, JIMT-1, BT474-EEI, HCC-1954, MCF-7, CALU-3, SKOV-3, 和MKN-7 | ||
濃度 | 溶于DMSO,終濃度為~10 μM | |||
孵育時間 | 48,和72小時 | |||
方法 | 使用不同濃度 GDC-0941處理細胞48,和 72小時。通過CellTiter-Glo Luminescent細胞活性檢測實驗測定細胞增殖/活力。通過Western Blot分析pAKT (Ser473), cleaved caspase-3, 和cleaved PARP通過 Caspase-Glo 3/7實驗和細胞死亡檢測 ELISAplus 實驗分別測定caspase 3/7活性, 和凋亡。 |
|||
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot | p-AKT / AKT / p-FoxO3a / FoxO3a / PUMA p-S6RP / S6RP p-4EBP1 / 4EBP1 p-LRP6 / LRP6 p-PAK / PAK1 / p-CRAF / RAF / p-MEK / MEK / p-ERK / ERK |
![]() |
29137323 | |
Immunofluorescence | p65 beta-catenin |
![]() |
30042442 | |
Growth inhibition assay | Cell viability |
![]() |
27117832 |
體內研究(In Vivo) | ||
體內研究活性 | 在微粒體中,GDC-0941僅有有限的代謝,其口服生物利用度為78%[5]。GDC-0941 每天按 75 mg/kg劑量處理攜帶人U87MG 惡性膠質移植瘤的雌性NCr無胸腺小鼠,顯著抑制生長,腫瘤生長抑制率為 83%。[1]GDC-0941 每天按 150 mg/kg劑量口服處理攜帶HER2擴增的MDA-MB-361.1移植瘤 的小鼠,抑制腫瘤生長,且顯著延遲腫瘤衰退,與腫瘤中強誘導型凋亡相關。[2] GDC-0941 每天按75 mg/kg劑量處理攜帶自發(fā)性B細胞濾泡性淋巴瘤的PTEN+/-LKB1+/hypo小鼠,持續(xù)2周,誘導腫瘤體積下降~40%,伴隨著AKT, S6K 和SGK(血清和糖皮質激素蛋白激酶)蛋白激酶的磷酸化被切除。GDC-0941抑制腫瘤細胞增殖,誘導凋亡和抑制中心母細胞數(shù)。[3] |
|
---|---|---|
動物實驗 | Animal Models | 移植MDA-MB-361.1細胞的NCR裸鼠, 皮下移植BT474-M1 細胞的SCID, C.B-17/IcrHsd-Prkdcscid 小鼠 |
Dosages | ~150 mg/kg/day | |
Administration | 口服飼喂 |
NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
---|---|---|---|---|---|
NCT02092831 | Completed | Healthy Volunteer |
Genentech Inc. |
April 2014 | Phase 1 |
NCT01740336 | Completed | Breast Cancer |
Genentech Inc. |
February 6 2013 | Phase 2 |
NCT01474668 | Completed | Healthy Volunteer |
Genentech Inc. |
October 2011 | Phase 1 |
NCT01240226 | Completed | Healthy Volunteer |
Genentech Inc. |
November 2010 | Phase 1 |
分子量 | 513.64 | 分子式 | C23H27N7O3S2 |
CAS號 | 957054-30-7 | SDF | Download Pictilisib (GDC-0941) SDF |
Smiles | CS(=O)(=O)N1CCN(CC1)CC2=CC3=C(S2)C(=NC(=N3)C4=C5C=NNC5=CC=C4)N6CCOCC6 | ||
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 100 mg/mL ( (194.68 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Water : Insoluble Ethanol : Insoluble |
摩爾濃度計算器 |
體內溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內配方計算器 |
動物體內配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項